Advanced search
Publication Cover
Cancer Investigation Volume 19, 2001 - Issue 6
Submit an article Journal homepage
110
Views
32
CrossRef citations to date
0
Altmetric
Original

Economic Analysis of Granulocyte Colony Stimulating Factor as Adjunct Therapy for Older Patients with Acute Myelogenous Leukemia (AML): Estimates from a Southwest Oncology Group Clinical Trial

Charles L. Bennett VA Chicago Health Care System—Lakeside, Chicago, Illinois, U.S.A.
, M.D., Ph.D.,
Denise Hynes Departments of Medicine, Loyola University, Maywood, Illinois, U.S.A.
, Ph.D.,
John Godwin Departments of Medicine, Loyola University, Maywood, Illinois, U.S.A.
, M.D.,
Tammy J. Stinson Department of Medicine, Division of Hematology/Oncology, Northwestern University, Chicago, Illinois, U.S.A.
, M.S.,
Robert M. Golub Department of Medicine, Division of General Internal Medicine, Northwestern University, Chicago, Illinois, U.S.A.
, M.D. &
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center, Seattle, Washington, U.S.A.
, M.D.
Pages 603-610 | Published online: 31 Jul 2001

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jiasheng Wang, Marcos de Lima, Brenda W. Cooper, Kirsten Boughan, Leland Metheny, Folashade Otegbeye, Paolo F. Caimi, Molly Gallogly, Ehsan Malek, Shufen Cao, Pingfu Fu, Brett Glotzbecker, Nicholas K. Schiltz & Benjamin K. Tomlinson. (2021) Efficacy and cost-benefit of filgrastim administered after early assessment bone marrow biopsy during induction therapy for acute myeloid leukemia. Leukemia & Lymphoma 62:6, pages 1450-1457.
Read now

Articles from other publishers (31)

Ereny Samwel Poles Saad, Karima Oualla, Narmin Talibova, Snezhanna Gening & Shady Gayed YousefYousef. (2022) Afebrile chemotherapy-induced neutropenia: an international survey spots oncologists’ routine clinical practice versus the standard of care and the impact of COVID-19. Supportive Care in Cancer 30:12, pages 9921-9928.
Crossref
Van T. Nghiem, Riha Vaidya, Gary H. Lyman, Dawn L. Hershman, Scott D. Ramsey & Joseph M. Unger. (2020) Economic Evaluations in National Cancer Institute–Sponsored Network Cancer Clinical Trials. Value in Health 23:12, pages 1653-1661.
Crossref
Nicole Skoetz, Julia Bohlius, Andreas Engert, Ina Monsef, Oliver Blank & Jörg-Janne Vehreschild. (2015) Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy. Cochrane Database of Systematic Reviews 2015:12.
Crossref
Andrew J. Cowan, William A. Altemeier, Christine Johnston, Terry Gernsheimer & Pamela S. Becker. (2014) Management of Acute Myeloid Leukemia in the Intensive Care Setting. Journal of Intensive Care Medicine 30:7, pages 375-384.
Crossref
Ronit Gurion, Yulia Belnik-Plitman, Anat Gafter-Gvili, Mical Paul, Liat Vidal, Isaac Ben-Bassat, Ofer Shpilberg & Pia Raanani. (2012) Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia. Cochrane Database of Systematic Reviews.
Crossref
Ronit Gurion, Yulia Belnik-Plitman, Anat Gafter-Gvili, Mical Paul, Liat Vidal, Isaac Ben-Bassat, Ofer Shpilberg & Pia Raanani. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Meral Beksac, Ridvan Ali, Tulay Ozcelik, Muhit Ozcan, Osman Ozcebe, Mahmut Bayik, Semra Paydas, Yahya Buyukasik, Osman Ilhan, Fahir Ozkalemkas, Gunhan Gurman, Akin Uysal, Hamdi Akan, Ender Akcaglayan Soydan & Ahmet Tunali. (2011) Short and long term effects of granulocyte colony-stimulating factor during induction therapy in acute myeloid leukemia patients younger than 65: Results of a randomized multicenter phase III trial. Leukemia Research 35:3, pages 340-345.
Crossref
Yulia Belnik-Plitman, Ronit Gurion, Anat Gafter-Gvili, Mical Paul, Liat Vidal, Isaac Ben-Bassat, Ofer Shpilberg & Pia Raanani. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Olga Frankfurt & Martin S. Tallman. 2011. Hematopoietic Growth Factors in Oncology. Hematopoietic Growth Factors in Oncology 307 337 .
Narissa J. Nonzee, Neal A. Dandade, Talar Markossian, Mark Agulnik, Athanassios Argiris, Jyoti D. Patel, Robert C. Kern, Hidayatullah G. Munshi, Elizabeth A. Calhoun & Charles L. Bennett. (2008) Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis. Cancer 113:6, pages 1446-1452.
Crossref
Frederick R. Appelbaum. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 2215 2234 .
Charles L. Bennett & Karen A. Fitzner. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 337 342 .
Tjakiena Henriette Levenga & Johanna N. H. Timmer‐Bonte. (2007) Review of the value of colony stimulating factors for prophylaxis of febrile neutropenic episodes in adult patients treated for haematological malignancies. British Journal of Haematology 138:2, pages 146-152.
Crossref
Frida Kasteng, Patrik Sobocki, Christer Svedman & Jonas Lundkvist. (2007) Economic evaluations of leukemia: A review of the literature. International Journal of Technology Assessment in Health Care 23:1, pages 43-53.
Crossref
M. R. Nowrousian, M. Poser & O. Kloke. 2007. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie 1405 1430 .
Ann M. Mauer, Elizabeth S. Rich & Richard L. Schilsky. 2007. Cancer Clinical Trials: Proactive Strategies. Cancer Clinical Trials: Proactive Strategies 111 129 .
Laura M. Katz, Jamie B. Howell, John J. Doyle, Lee S. Stern, Lisa C. Rosenblatt, Catherine Tak Piech & Marya D. Zilberberg. (2006) Outcomes and charges of elderly patients with acute myeloid leukemia. American Journal of Hematology 81:11, pages 850-857.
Crossref
Joel Gingerich & Eric J. Bow. (2006) Approach to the Complications of Treatment for Acute Leukemia in the Elderly. Seminars in Hematology 43:2, pages 134-143.
Crossref
F Ravandi. (2006) Role of cytokines in the treatment of acute leukemias: a review. Leukemia 20:4, pages 563-571.
Crossref
Farhad Ravandi & Partow Kebriaei. 2005. Cytokines and Cancer. Cytokines and Cancer 313 331 .
Carrie Cappozzo. (2004) Optimal Use of Granulocyte-Colony-Stimulating Factor in Patients With Cancer Who Are at Risk for Chemotherapy-Induced Neutropenia. Oncology Nursing Forum 31:3, pages 569-576.
Crossref
Alberto Redaelli, Marc F Botteman, Jennifer M Stephens, Suzanne Brandt & Chris L Pashos. (2004) Economic burden of acute myeloid leukemia: a literature review. Cancer Treatment Reviews 30:3, pages 237-247.
Crossref
C. Löfgren, C. Paul, M. Åström, R. Hast, M. Hedenius, R. Lerner, J. Liliemark, I. Nilsson, S. Rödjer, B. Simonsson, D. Stockelberg, U. Tidefelt & M. Björkholm. (2004) Granulocyte‐macrophage colony‐stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial. British Journal of Haematology 124:4, pages 474-480.
Crossref
John E. Godwin & Scott E. Smith. (2003) Acute myeloid leukemia in the older patient. Critical Reviews in Oncology/Hematology 48, pages S17-S26.
Crossref
Scott B. Cantor, Linda S. Elting, David V. Hudson & Edward B Rubenstein. (2003) Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy. Cancer 97:12, pages 3099-3106.
Crossref
Brenda K Shelton. (2003) Evidence-based care for the neutropenic patient with leukemia. Seminars in Oncology Nursing 19:2, pages 133-141.
Crossref
Charles L Bennett & Glen T Schumock. (2003) Cost Analyses Of Adjunct Colony Stimulating Factors For Older Patients With Acute Myeloid Leukaemia. Drugs & Aging 20:7, pages 479-483.
Crossref
D.H. Smith, J.R. Adams, S.R.D. Johnston, A. Gordon, M.F. Drummond & C.L. Bennett. (2002) A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK. Annals of Oncology 13:10, pages 1590-1597.
Crossref
Gary H. Lyman, Nicole M. Kuderer & Lodovico Balducci. (2002) Cost-benefit analysis of granulocyte colony-stimulating factor in the management of elderly cancer patients. Current Opinion in Hematology 9:3, pages 207-214.
Crossref
. (2002) Current Awareness in Hematological Oncology. Hematological Oncology 20:1, pages 43-50.
Crossref
Lodovico Balducci & Ignazio Carreca. (2002) The Role of Myelopoietic Growth Factors in Managing Cancer in the Elderly. Drugs 62:Supplement 1, pages 47-63.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.